BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25712352)

  • 21. A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015.
    Wind CM; Bruisten SM; Schim van der Loeff MF; Dierdorp M; de Vries HJC; van Dam AP
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373191
    [No Abstract]   [Full Text] [Related]  

  • 22. High Prevalence of Azithromycin-Resistant Neisseria gonorrhoeae Isolates With a Multidrug Resistance Phenotype in Fukuoka, Japan.
    Tanaka M; Furuya R; Irie S; Kanayama A; Kobayashi I
    Sex Transm Dis; 2015 Jun; 42(6):337-41. PubMed ID: 25970312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
    Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
    Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae.
    Ng LK; Martin I; Liu G; Bryden L
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3020-5. PubMed ID: 12183262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance.
    Trembizki E; Buckley C; Donovan B; Chen M; Guy R; Kaldor J; Lahra MM; Regan DG; Smith H; Ward J; Whiley DM
    J Antimicrob Chemother; 2015 Dec; 70(12):3244-9. PubMed ID: 26338048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Microbiological Efficacy of a Single 2-Gram Dose of Extended-Release Azithromycin by Population Pharmacokinetics and Simulation in Japanese Patients with Gonococcal Urethritis.
    Soda M; Ito S; Matsumaru N; Nakamura S; Nagase I; Takahashi H; Ohno Y; Yasuda M; Yamamoto M; Tsukamoto K; Itoh Y; Deguchi T; Kitaichi K
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic Characterization of Neisseria gonorrhoeae Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin.
    Schmerer MW; Abrams AJ; Seby S; Thomas JC; Cartee J; Lucking S; Vidyaprakash E; Pham CD; Sharpe S; Pettus K; St Cyr SB; Torrone EA; Kersh EN; ; Gernert KM;
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.
    Tanaka M; Nakayama H; Huruya K; Konomi I; Irie S; Kanayama A; Saika T; Kobayashi I
    Int J Antimicrob Agents; 2006 Jan; 27(1):20-6. PubMed ID: 16318912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
    Singh AE; Gratrix J; Read R; Lovgren M; Drews SJ; Romanowski B; Sutherland K; Talbot J; Martin I
    Sex Transm Dis; 2013 Sep; 40(9):744-50. PubMed ID: 23945428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae.
    Furuya R; Nakayama H; Kanayama A; Saika T; Iyoda T; Tatewaki M; Matsuzaki K; Kobayashi I; Tanaka M
    J Infect Chemother; 2006 Aug; 12(4):172-6. PubMed ID: 16944253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial Resistance And Molecular Characteristics Among
    Zheng Z; Liu L; Shen X; Yu J; Chen L; Zhan L; Chen H; Lin C; Jiang Y; Xia H; Wang L; Yu F
    Infect Drug Resist; 2019; 12():3301-3309. PubMed ID: 31695449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy.
    Starnino S; Stefanelli P;
    J Antimicrob Chemother; 2009 Jun; 63(6):1200-4. PubMed ID: 19357159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.
    Hamasuna R; Yasuda M; Ishikawa K; Uehara S; Hayami H; Takahashi S; Matsumoto T; Yamamoto S; Minamitani S; Watanabe A; Iwata S; Kaku M; Kadota J; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Naito S; Kuroiwa K; Hirayama H; Narita H; Hosobe T; Ito S; Ito K; Kawai S; Ito M; Chokyu H; Matsumura M; Yoshioka M; Uno S; Monden K; Takayama K; Kaji S; Kawahara M; Sumii T; Kadena H; Yamaguchi T; Maeda S; Nishi S; Nishimura H; Shirane T; Yoh M; Akiyama K; Imai T; Kano M
    J Infect Chemother; 2015 May; 21(5):340-5. PubMed ID: 25727286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study.
    Fifer H; Cole M; Hughes G; Padfield S; Smolarchuk C; Woodford N; Wensley A; Mustafa N; Schaefer U; Myers R; Templeton K; Shepherd J; Underwood A
    Lancet Infect Dis; 2018 May; 18(5):573-581. PubMed ID: 29523496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of Neisseria gonorrhoeae Strains Harboring a Novel Combination of Azithromycin-Attenuating Mutations.
    Pham CD; Sharpe S; Schlanger K; St Cyr S; Holderman J; Steece R; Soge OO; Masinde G; Arno J; Schmerer M; Kersh EN;
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With Neisseria gonorrhoeae Infection at a Sexual Health Clinic: 2012-2019.
    Rowlinson E; Soge OO; Hughes JP; Berzkalns A; Thibault C; Kerani RP; Khosropour CM; Manhart LE; Golden MR; Barbee LA
    Clin Infect Dis; 2023 Feb; 76(3):e1270-e1276. PubMed ID: 36001447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae.
    Cousin SL; Whittington WL; Roberts MC
    J Antimicrob Chemother; 2003 Jan; 51(1):131-3. PubMed ID: 12493797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for Clonally Associated Increasing Rates of Azithromycin Resistant
    Barros Dos Santos KT; Skaf LB; Justo-da-Silva LH; Medeiros RC; Francisco Junior RDS; Caniné MCA; Fracalanzza SEL; Bonelli RR
    Biomed Res Int; 2019; 2019():3180580. PubMed ID: 30800666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
    Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
    J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland.
    Palmer HM; Young H; Winter A; Dave J
    J Antimicrob Chemother; 2008 Sep; 62(3):490-4. PubMed ID: 18552343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.